Consensus RadNet, Inc.

Stocks

RDNT

US7504911022

Healthcare Facilities & Services

Market Closed - Nasdaq Other stock markets 21:00:00 11/06/2026 BST			After hours 00:55:06
58.20 ^USD	+0.07%		58.32	+0.20%

06-10	Radnet, Inc. Enters into Incremental Amendment No. 3 to Credit and Guaranty Agreement, Secures $250 Million Incremental Term Loan and Reduces Interest Rates on Credit Facility	CI
06-10	RadNet-Owned DeepHealth Launches AI Radiology Reporting Software	MT

Evolution of the Average Target: RadNet, Inc.

Evolution of the Target Price: RadNet, Inc.

Changes in Analyst Recommendations: RadNet, Inc.

d50dbdb2b4e.akYZMaHThSA-RppGsM5LIsRggdO3xMZQhV1Ah1fvWyw.Pz9BW8fhzFVIMdQ39rQASZsH8bXcvJcT0BAEwG69FUQHLmxa8IriFW8erg~34b7b9b8aa9b2ed0f63f0002bbd30bf3

Analysts' recommendations: RadNet, Inc.

05-01	B. Riley Adjusts Price Target on RadNet to $83 From $87, Maintains Buy Rating	MT
12-01	B. Riley Raises Price Target on RadNet to $87 From $71, Keeps Buy Rating	MT
11-12	Truist Raises Price Target on RadNet to $90 From $81, Keeps Buy Rating	MT
03/09/25	Truist Raises Price Target on RadNet to $81 From $74, Keeps Buy Rating	MT
12/08/25	B. Riley Adjusts Price Target on RadNet to $71 From $69, Maintains Buy Rating	MT
13/06/25	B. Riley Initiates RadNet at Buy With $69 Price Target	MT
17/04/25	RadNet's iCAD Deal to Expand its Digital Health Services and Geographic Presence, Truist Says	MT
11/04/25	Truist Securities Cuts Price Target on RadNet to $74 From $88, Keeps Buy Rating	MT
22/01/25	Truist Securities Cuts Price Target on RadNet to $88 From $94, Keeps Buy Rating	MT
29/11/24	Truist Raises Price Target on RadNet to $94 From $80, Keeps Buy Rating	MT
11/11/24	Top Midday Gainers	MT
04/10/24	Sidoti Adjusts RadNet Price Target to $88 From $72, Maintains Buy Rating	MT
23/09/24	Truist Raises Price Target on RadNet to $80 From $70, Maintains Buy Rating	MT
06/09/24	Barclays Upgrades RadNet to Overweight From Equal Weight	MT
15/07/24	Truist Securities Adjusts Price Target on RadNet to $70 From $63, Maintains Buy Rating	MT
11/07/24	Jefferies Adjusts Price Target on RadNet to $75 From $61, Maintains Buy Rating	MT
15/05/24	Truist Securities Adjusts Price Target on RadNet to $63 From $55, Maintains Buy Rating	MT
28/03/24	Truist Securities Raises Price Target on RadNet to $55 From $51, Maintains Buy Rating	MT
06/03/24	Barclays Starts Coverage on RadNet With Equalweight Rating, $48 Price Target	MT
04/03/24	Truist Securities Adjusts RadNet Price Target to $51 From $42, Maintains Buy Rating	MT
08/12/23	Truist Adjusts RadNet's Price Target to $42 From $40, Maintains Buy Rating	MT
31/08/23	Truist Securities Starts RadNet at Buy With $40 Price Target	MT
26/06/23	Raymond James Raises Price Target on RadNet to $40 From $35, Keeps Outperform Rating	MT
10/05/23	Raymond James Adjusts Price Target on RadNet to $35 From $30, Maintains Outperform Rating	MT
31/03/23	CJS Securities Initiates RadNet at Outperform With $30 Price Target	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	RADNET, INC.					+54.32%
	NATERA, INC.					+19.75%
	LABCORP HOLDINGS INC.					+15.44%
	SONIC HEALTHCARE LIMITED					+22.18%
	DR. LAL PATHLABS LIMITED					+7.48%
	GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.					+26.24%
	GENEDX HOLDINGS CORP.					+41.75%
	FLEURY S.A.					+16.43%
	DIAN DIAGNOSTICS GROUP CO.,LTD.					+13.24%
	NEOGENOMICS, INC.					+33.47%
	Average					+25.03%
	Weighted average by Cap.					+21.11%